Vantage Investment Advisors’s ERBA DIAGNOSTICS ERB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-8,878
| Closed | -$2K | – | 878 |
|
|
2017
Q3 | $2K | Hold |
8,878
| – | – | ﹤0.01% | 755 |
|
|
2017
Q2 | $2K | Buy |
8,878
+6,660
| +300% | +$1.5K | ﹤0.01% | 730 |
|
|
2017
Q1 | $1K | Hold |
2,218
| – | – | ﹤0.01% | 749 |
|
|
2016
Q4 | $1K | Sell |
2,218
-1,500
| -40% | -$676 | ﹤0.01% | 779 |
|
|
2016
Q3 | $2K | Hold |
3,718
| – | – | ﹤0.01% | 719 |
|
|
2016
Q2 | $3K | Hold |
3,718
| – | – | ﹤0.01% | 703 |
|
|
2016
Q1 | $4K | Hold |
3,718
| – | – | ﹤0.01% | 667 |
|
|
2015
Q4 | $5K | Hold |
3,718
| – | – | ﹤0.01% | 625 |
|
|
2015
Q3 | $7K | Hold |
3,718
| – | – | ﹤0.01% | 583 |
|
|
2015
Q2 | $8K | Sell |
3,718
-19,282
| -84% | -$57.4K | ﹤0.01% | 542 |
|
|
2015
Q1 | $81K | Buy |
23,000
+11,500
| +100% | +$40.3K | 0.02% | 269 |
|
|
2014
Q4 | $36K | Hold |
11,500
| – | – | 0.02% | 284 |
|
|
2014
Q3 | $40K | Sell |
11,500
-1,000
| -8% | -$2.84K | 0.02% | 253 |
|
|
2014
Q2 | $25K | Hold |
12,500
| – | – | 0.02% | 339 |
|
|
2014
Q1 | $32K | Sell |
12,500
-2,500
| -17% | -$7.38K | 0.02% | 273 |
|
|
2013
Q4 | $41K | Buy |
+15,000
| New | +$28.5K | 0.03% | 231 |
|
Vantage Investment Advisors's ERB Position: Q4 2017 in Review
Vantage Investment Advisors sold out of ERBA DIAGNOSTICS (ERB) in Q4 2017, closing a stake of 8,878 shares — an estimated $2K sold.
Vantage Investment Advisors first reported a position in ERB in Q4 2013 and held it in 16 quarters. The position peaked at $81K in Q1 2015. 0 funds tracked by Wall St. Rank hold ERB as of Q4 2017.
- Vantage Investment Advisors reported no remaining ERBA DIAGNOSTICS position as of Q4 2017 after selling out during the quarter.
- Vantage Investment Advisors sold 8,878 ERBA DIAGNOSTICS shares in Q4 2017, an estimated $2K.
- Vantage Investment Advisors first reported a position in ERBA DIAGNOSTICS in Q4 2013 and held it in 16 quarters.
- Vantage Investment Advisors's ERBA DIAGNOSTICS position peaked at $81K in Q1 2015.
- 0 funds tracked by Wall St. Rank held ERBA DIAGNOSTICS as of Q4 2017.
Based on Vantage Investment Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.